InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by BENNETT C FRANK, VP Exécutif. Insider active across 1 companies, notably Ionis Pharmaceuticals INC. Cumulatively, 7 reports have been logged. The latest transaction was filed on 3 March 2026 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
US$458,82016,463 shares@ US$27.86970.0036% mcap99.1% of flow
Common Stock
SEC:0000874015-26-000134·
€458,82016,463 shares@ €27.86970.0036% mcap49.1% of flow
Common Stock
SEC:0000874015-26-000134:0·
€8,780346 shares@ €25.3760.0001% mcap0.9% of flow
Common Stock
SEC:0000874015-22-000086:0·
018,842 shares0
Common Stock
SEC:0000874015-22-000056·
018,842 shares0
Common Stock
SEC:0000874015-22-000056:0·
€4,321151 shares@ €28.61570.0000% mcap0.9% of flow
Common Stock
SEC:0000874015-21-000151·
€4,321151 shares@ €28.61570.0000% mcap0.5% of flow
Common Stock
SEC:0000874015-21-000151:0·
7 of 7 declarations
About BENNETT C FRANK
Frank C. Bennett is the Executive Vice President and Chief Scientific Officer at Ionis Pharmaceuticals Inc. He plays a key role in the development of new therapies and scientific research within the company. With deep expertise in the pharmaceutical field, Frank C. Bennett contributes to innovation and the advancement of medical treatments, thereby strengthening Ionis Pharmaceuticals' position in the market.
